MVIS vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

MVIS

47.5
AI Score
VS
MVIS Wins

CLOV

33.5
AI Score

Investment Advisor Scores

MVIS

48score
Recommendation
HOLD

CLOV

34score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric MVIS CLOV Winner
Forward P/E 0 37.7358 Tie
PEG Ratio -0.51 0 Tie
Revenue Growth 850.3% 55.6% MVIS
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 47.5/100 33.5/100 MVIS
Profit Margin 0.0% -0.7% MVIS
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY MVIS

Relative Price Performance (Last 90 Days)

MVIS 1M: -10.3% · 3M: +306.9% CLOV 1M: +1.9% · 3M: -13.4%

Current Technical Phase

MVIS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.7 · Price: $1.48

CLOV

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -3.2%) with fading momentum, RSI 48

RSI (14): 47.6 · Price: $4.38

Fundamentals Snapshot

Metric MVIS CLOV
Market Cap — —
Forward P/E -8.7 29.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 8.5% 0.6%
Gross Margin -5.5% 0.2%
Operating Margin -14.9% 0.0%
EPS -5.52 -0.05
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MVIS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.